The largest database of trusted experimental protocols

35 protocols using ezglp1t 36k

1

Metabolic and Hormonal Analysis in Mice and Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained directly from the left ventricles of mice and rats after a 10‐hour fast and/or combined stress for 4 hours for the ELISA and biochemical analyses. The levels of plasma GLP‐1 protein (cat. no. EZGLP1T‐36K; EMD Millipore, Billerica, MA) and the cell extract Adrβ3 activity (cat. no. MBS2022034; MyBioSource, San Diego, CA) were determined using the commercially available ELISA kits according to the manufacturer's instructions. The blood cell analysis of the rats and the levels of the mouse and rat plasma glucose, triglyceride, total cholesterol, high‐density lipoprotein cholesterol, aspartate transaminase, blood urea nitrogen, creatinine, nonesterified fatty acid (NEFA), epinephrine, norepinephrine, and catecholamine were examined at a commercial laboratory (SRL, Tokyo, Japan).
+ Open protocol
+ Expand
2

Quantifying GLP-1 and Metabolic Hormones

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intestinal tissue segments (0.5 cm length) were homogenized, lysed (1 M Tris-HCl, 5 M NaCl, 1% (v/v) Igepal CA-630, 0.5% (w/v) sodium deoxycholate monohydrate, and one tablet of EDTA-free protease inhibitor cocktail), and centrifuged to prepare the tissue extracts. GLP-1 levels in the plasma, cell culture supernatants, and tissue extracts were measured using an active GLP-1 (7–36 and 7–37; EGLP-35K) or total GLP-1 (7–36 and 9–36; EZGLP1T-36K) ELISA kit (EMD Millipore, USA). The quantification of GLP-1 levels in cell culture supernatants and tissue extracts was normalized to the protein levels of cell or tissue lysates, which were determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, USA). Other hormones, including peptide YY (PYY), ghrelin, insulin, and C-peptide, were measured using a mouse metabolic hormone expanded panel kit (EMD Millipore, USA).
+ Open protocol
+ Expand
3

Multiplex Biomarker Quantification in Primates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human serum LCN2, insulin, and GLP-1 were quantitated using commercially available ELISA kits and following the manufacturer’s instructions (#DY1757, R and D Systems, Minneapolis, MN;#90095, CrystalChem, Inc, Elk Grove Village, IL,; #EZGLP1T-36K, Merck, Burlington, MA, respectively). Monkey LCN2 and insulin were assayed with ELISA kits from LifeSpan BioSciences (#LS-F38530 and LS-F10306 respectively; Lifespan Biosciences, Inc, Seattle, WA) and leptin with an ELISA kit from Cusabio (#CSB-E14936Mk, Cusabio, Houston, TX). Circulating levels of primate CRP were determined using a commercially available ELISA kit using the manufacturer’s instructions (911CRP01P-96; Helica Biosystems, Inc, Santa Ana, CA). Blood chemistry was performed using a Heska Element DC Veterinary Chemistry Analyzer (Heska, Loveland, CO) at Columbia University’s Institute of Comparative Medicine Diagnostic Laboratory.
+ Open protocol
+ Expand
4

Serum GLP-1 and GLP-2 Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum GLP-1 and GLP-2 levels were analyzed by enzyme-linked immunosorbent assay (ELISA) (EZGLP1T-36K and EZGLP2-37K, respectively, EMD Millipore, USA) according to the manufacturer’s protocols. Serum was kept at −70°C until use. All incubations were performed at room temperature on an orbital shaker at 400 rpm, and samples were tested in duplicate (50 μl/well). Standards, blanks, quality controls and sera were distributed in the precoated wells and incubated for 1.5 h for GLP-1 and 2 h for GLP-2 at room temperature. Plates were rewashed and incubated with primary antibody for 1 h (GLP-1) or 30 min (GLP-2). After washing, the plates were incubated with horseradish peroxidase-conjugated secondary antibody for 30 min (for both GLP-1 and GLP-2). After washing, plates were incubated with tetramethylbenzidine for 10–15 min in the dark for color development, followed by addition of 1 M H2SO4 to stop the reaction. Plates were read by a Multiskan-EX ELISA plate reader (Thermo, USA) within 5 min. The absorbance was measured at wavelengths of 450 nm and 590 nm. Total GLP-1 was measured in pmol/l, GLP-2 in ng/ml, and both were calculated according to the manufacturer’s protocol and resulting standard curve.
+ Open protocol
+ Expand
5

Gut Biomarkers and Metabolic Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stool samples were collected by subjects at home within maximum 48 h prior to the study visits. Stool samples were directly frozen at subjects’ home after collection (within 10 min) and returned to study site in a frozen state. The stool biomarkers SCFAs (acetate, butyrate, propionate) were analyzed by gas chromatography at Enterosan Labor LS SE & Co. KG, an accredited lab (Bad Bocklet-Großenbrach, Germany). Blood sampling was performed at each visit after at least 10 h overnight fast. For the assessment of total GLP-1 and PYY, DPP-IV and AEBSF inhibitor was added to the EDTA-plasma tube prior to blood collection. Total GLP-1 and PYY were analyzed in plasma utilizing ELISA technique with technical duplicates for each sample according to the manufacturers protocol (Merck Millipore EZGLP1T-36K for total GLP-1 and EZHPYYT66K for PYY). Lipid status (triglycerides, total cholesterol, HDL- and LDL-cholesterol) and further safety blood routine measures were determined in an accredited routine lab at Synlab Medizinisches Versorgungszentrum Leinfelden (Leinfelden, Germany). Stool frequency and consistency by means of the Bristol stool scale were reported daily in a diary. Fiber intake was estimated with a 3-days food protocol and evaluated with EBISpro (Dr. Ehrhardt, Willstätt-Legelshurst, Germany) based on the German Nutrient Data Base.
+ Open protocol
+ Expand
6

Comprehensive Metabolic Profile Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Urine, drink and serum samples were analysed in duplicate for osmolality by freezing point depression (Gonotec Osmomat 030, Gonotec, Berlin, Germany). To prevent the degradation of acylated ghrelin, 50 µL of Pefabloc (Roche Diagnostics Limited, Burgess Hill, UK) was immediately added to blood samples. Blood samples were centrifuged at 1500× g for 15 min at 4 °C and the serum aliquoted and stored at −80 °C until analysis was performed. Serum glucose, lactate, and triglyceride concentrations were determined in duplicate using a clinical chemistry analyser (Randox Daytona, Crumlin, UK). Serum fructose concentration was determined using a colorimetric assay (EnzyChrom™ EFRU-100; BioAssay Systems, Hayward, CA, USA). Circulating concentrations of acylated ghrelin, insulin, GIP, and leptin were determined using multiplex analysis (Luminex 200, Luminex Corporation, Austin, TX, USA) with kits purchased from Merck-Millipore (HMHMAG-34K, Milliplex MAP, Merck Millipore Ltd., Feltham, UK). Circulating concentrations of total GLP-1 were determined in duplicate using Enzyme Linked Immunoassay (EZGLP1T-36K, Merck Millipore Ltd., Feltham, UK).
+ Open protocol
+ Expand
7

GLP-1 Secretion Assay for NCI-h716 and HuTu-80 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCI-h716 and HuTu-80 cells were cultivated in respectively RPMI and DMEM, both supplemented with 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine and 50 IU ml−1 penicillin and 50 µg ml−1 streptomycin in humidified incubator at 37°C with 5% CO2. Oxygen consumption and secretion assays were performed in a secretion buffer composed of NaCl 140 mM, KCl 5 mM, MgCl2 2 mM, CaCl2 2 mM, Hepes 10 mM, pH adjusted to 7.3. Na2S (from Sigma) was dissolved in the secretory buffer and pH adjusted to 7.3 with NaOH.
For secretion, 4 million cells per sample were rinsed in secretion buffer and resuspended in 2mL. Na2S was added either every 90s or at once, all resulting in the same final volume of 2.1mL. After 15 minutes of experiment, cells were centrifuged at 300g at 4°C and supernatant was frozen at -20°C. GLP-1 was then measured using a GLP-1 Elisa (EZGLP1T-36K from Merck Millipore) and data analyzed using R. Experiments were performed in duplicate and replicated 4 times, resulting in 8 independent measures of GLP-1 in each condition. Data were normalized with the basal secretion of each experiment and differences between conditions assessed using a Kruskall-Wallis test followed by a Dunn test, excluding the positive control Forskolin/IBMX high glucose from the analysis. A p adjusted value below 0.05 was considered to indicate difference between groups.
+ Open protocol
+ Expand
8

Glucose, HbA1c, and Incretin Hormones

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma concentrations of glucose and HbA1c were measured by the glucose oxidase method (Roche Diagnostics, Basel, Switzerland) and high‐performance liquid chromatography method (TSKgel® G8 His; Tosoh Corp., Tokyo, Japan). Serum levels of insulin, total GLP‐1 and total glucose‐dependent insulinotropic polypeptide (GIP) were measured by enzyme‐linked immunosorbent assay kits (Lumipulse Presto 2 [Fujirebio Inc., Tokyo, Japan], EZGLP1T‐36K [Merck Millipore, Darmstadt, Germany] and EZHGIP‐54K [Merck Millipore], respectively). The area under the curve (AUC) of each of the measurements was calculated according to the trapezoid rule. The insulinogenic index (an index of insulin secretory capacity) and Matsuda index (an index of insulin sensitivity) was calculated as previously described20.
+ Open protocol
+ Expand
9

GLP-1 Measurement in Plasma Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patients were subjected to pre-operative fasting and plasma samples were collected before surgery, placed immediately on ice and transferred to −80 °C. The total GLP-1 (7–36 and 9–36) (Cat. No.: EZGLP1T-36K, Merck, Darmstadt, Germany) was measured according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Biomarker Profiling of Metabolic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmatic lipid, hepatic and renal profiles were determined by standard enzymatic methods. Plasma glucose was determined by the glucose oxidase method (ADVIA Centaur; Siemens Healthcare, Erlangen, Germany and GM-9; Analox, London, U.K.) Plasma insulin and C-peptide levels were determined by an immunochemiluminometric assay (ADVIA Centaur). Total plasma glucagon-like peptide 1 (GLP-1) levels were determined by radioimmunoassay (GLP-1T-36HK) or by ELISA (EZGLP1T-36 K) in cohorts I and II/III, respectively (both from Merck KGaa, Darmstadt, Germany) (17 (link)). Plasma succinate was determined in plasma filtrates (10 KDa) using a fluorometric assay (EnzyChrom Succinate Assay Kit; BioAssay Systems, Hayward, CA) (9 (link),12 (link),14 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!